stockrowIncannex Healthcare Inc.
IXHLHealthcare Drug Manufacturers Specialty & Generic
Incannex Healthcare Inc.’s revenue for fiscal 2025 (year ended June 2025) was $86,000.00, up 616.7% from fiscal 2024.
- Revenue
- −92.3%
- EPS
- +98.6%
- Free cash flow
- +327.7%
Quarter to June 2026, against a year earlier
Follow IXHL
Alert me
Incannex Healthcare Inc. (IXHL) Return on invested capital
Incannex Healthcare Inc.'s return on invested capital over the twelve months to 30 June 2026 was 0.00%. Over the past ten years it has ranged from −350.4% (fiscal 2024) to 0.00% (fiscal 2026) — the current reading is the highest in ten years. That is in line with the Drug Manufacturers Specialty & Generic industry median of 0.00% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2026 | 0.00% | 0.00 |
| FY2025 | 0.00% | 350.36 |
| FY2024 | −350.4% | (350.36) |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | 0.00 |
| FY2021 | 0.00% | 0.00 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| IXHL Incannex Healthcare Inc. | 0.00% |
| INCR InterCure Ltd. compare | 0.00% |
| ZYBT Zhengye Biotechnology Holding Limited compare | 0.00% |
| CPHI China Pharma Holdings, Inc. compare | −7.23% |
| TXMD TherapeuticsMD, Inc. compare | −13.8% |
| RMTI Rockwell Medical, Inc. compare | −14.6% |
| AYTU Aytu BioPharma, Inc. compare | −20.0% |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. compare | −36.7% |
| SCYX SCYNEXIS, Inc. compare | −110.7% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)